Alma Mihaljevic-Peles
Overview
Explore the profile of Alma Mihaljevic-Peles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bagaric T, Mihaljevic-Peles A, Skocic Hanzek M, Zivkovic M, Kozmar A, Rogic D
Curr Issues Mol Biol
. 2024 May;
46(5):4533-4550.
PMID: 38785543
Unipolar (UD) and bipolar depression (BDD) show a high degree of similarity in clinical presentations, which complicates the differential diagnosis of these disorders. The aim of this study was to...
2.
Latas M, Stefanovski B, Mihaljevic-Peles A, Memic Serdarevic A, Pajevic I, Radulovic N, et al.
PLoS One
. 2024 Jan;
19(1):e0295754.
PMID: 38166004
Introduction: This paper aims to examine the frequency and significance of diagnostic comorbidity of psychiatric disorders and somatic diseases in a sample of patients with depression as well as present...
3.
Nedic Erjavec G, Grubor M, Zivkovic M, Bozina N, Sagud M, Nikolac Perkovic M, et al.
Biomedicines
. 2022 Dec;
10(12).
PMID: 36551993
Antipsychotic-induced parkinsonism (AIP) is the most common type of extrapyramidal side effect (EPS), caused by the blockage of dopamine receptors. Since dopamine availability might influence the AIP risk, the dopamine...
4.
Rojnic Kuzman M, Slade M, Puschner B, Scanferla E, Bajic Z, Courtet P, et al.
Eur Psychiatry
. 2022 Oct;
65(1):e75.
PMID: 36266742
Background: While shared clinical decision-making (SDM) is the preferred approach to decision-making in mental health care, its implementation in everyday clinical practice is still insufficient. The European Psychiatric Association undertook...
5.
Marinovic P, Pavicic L, Prpic N, Sagud M, Janovic M, Jevtovic S, et al.
Psychiatr Danub
. 2022 Oct;
34(3):439-446.
PMID: 36256981
Introduction: Minor physical anomalies (MPA) are subtle morphological deviations with little to none clinical significance that are developed prenatally and therefore could be an indicator of structural changes in the...
6.
Bitter I, Mohr P, Raspopova N, Szulc A, Samochowiec J, Micluia I, et al.
Front Psychiatry
. 2022 Feb;
12:820801.
PMID: 35185643
Clinicians and researchers consider that there are a variety of symptoms that constitute negative symptoms in schizophrenia, and they may use different definitions for the same symptoms. These differences are...
7.
Medved S, Marcinko D, Bulum J, Mihaljevic-Peles A
Psychiatr Danub
. 2021 Oct;
33(Suppl 4):681-683.
PMID: 34718301
No abstract available.
8.
Medved S, Janovic M, Stimac Z, Mihaljevic-Peles A
J Psychiatr Pract
. 2021 Aug;
27(4):326-332.
PMID: 34398584
An increasing body of research has been published concerning the potential impact of oxytocin (OT) in the pathophysiology of neuropsychiatric disorders that affect social functioning, such as schizophrenia. The possible...
9.
Sagud M, Nikolac Perkovic M, Dvojkovic A, Jaksic N, Vuksan-Cusa B, Zivkovic M, et al.
Psychopharmacology (Berl)
. 2021 Feb;
238(6):1575-1584.
PMID: 33560444
Rationale: Cognitive dysfunction is frequent in major depressive disorder (MDD), and brain-derived neurotrophic factor (BDNF) is involved both in regulation of cognition and in therapeutic response in MDD. Objectives: The...
10.
Zivkovic M, Mihaljevic-Peles A, Muck-Seler D, Sagud M, Ganoci L, Vlatkovic S, et al.
Psychiatr Danub
. 2020 Apr;
32(1):84-91.
PMID: 32303037
Background: Symptomatic remission is an achievable goal in the treatment of schizophrenia. The type of antipsychotic medication and particular genetic variants of the dopaminergic system might be associated with remission....